Guest Writer

Researcher and author Johannes Lenhard writes that for LPs, the evidence is not necessarily enough yet to really put pressure on GPs to enact ESG principles, but they are starting to feel the heat.

Bernard Ross of Sky Medical Technology says that the European medtech market has grown in recent years and he expects it to keep rising since the region is ripe with innovation.

Matt McCooe of Connecticut Innovations writes that the stereotypical successful tech entrepreneur is not a nerdy white guy in jeans from Silicon Valley. Investors need to broaden their lens.

Robert R. Ackerman Jr. talks about fundraising not for one but for two firms amid an environment beset with multiple crises. Here’s his secret to managing through it.

Covid-19 has created uncertainty, and it has also paved the way for opportunities in certain sectors. Anis Uzzaman of Pegasus Tech Ventures says e-commerce, online education and e-sports are the three sectors that will remain relevant long after the pandemic.

Tom Walker of Rev1 Ventures addresses the question of whether investors should back biotech start-ups that focus on the coronavirus and other potential pandemics. Here's what you should know.

William Taranto of the Merck Global Health Innovation Fund writes how the switch to working from home can make investors more productive. But the downside is loss of personal interaction.

Times are difficult right now, but promising signs in regard to deals terms, impact investing and engagement are boding well, writes Oliver Libby, managing partner and co-founder of venture firm Hatzimemos / Libby.

The CEO of British Patient Capital writes, borrowing from its own name, that investing patient capital will help lift economy out of the pandemic.

As physical contact is reduced, the need and desire for a touchless economy is stronger than before.